EUS-FNA for Patients Taking Anticoagulants Without Heparin Bridge

NCT ID: NCT02977650

Last Updated: 2016-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the feasibility of EUS-FNA for patients taking anticoagulants without heparin bridge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endoscopic Ultrasonography-guided Fine Needle Aspiration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic ultrasonography-guided fine needle aspiration

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

EUS-FNA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Taking anticoagulants
* Written informed consent

Exclusion Criteria

* Platelets count less than 50000/μl
* PT-INR more than 2.6
* ASA more than 3
* Severe bleeding tendency
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hokkaido Pancreatobiliary Endoscopic Intervention Study Group

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kazumichi Kawakubo

M.D., Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hokkaido University Hospital

Sapporo, , Japan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Japan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kazumichi Kawakubo, Ph.D.

Role: CONTACT

Phone: 117161161

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kazumichi Kawakubo

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

016-0040

Identifier Type: -

Identifier Source: org_study_id